Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Monitoring manganese exposure
Nutritional monitoring
Clinical trials
Manganese (Mn), atomic number 25, atomic weight 54,938049, is a
trace essential element with many industrial uses. The 12th most
abundant element in the earth's crust, nearly all mined manganese
is consumed in the production of ferromanganese, which is then
used to remove oxygen and sulfur impurities from steel. These
industrial processes cause elevated environmental exposures to
airborne manganese dust and fumes, which in turn have lead to
well-documented cases of neurotoxicity among exposed workers.
Mining and iron and steel production have been implicated as
sources of exposure.
Inhalation is the primary source of entry for manganese toxicity.
Signs of toxicity may appear quickly or not at all; neurological
symptoms are rarely reversible. Manganese toxicity is generally
recognized to progress through 3 stages. Levy describes these
stages. "The first stage is a prodrome of malaise, somnolence, apathy,
emotional lability, sexual dysfunction, weakness, lethargy, anorexia,
and headaches. If there is continued exposure, progression to a
second stage may occur, with psychological disturbances, including
impaired memory and judgement, anxiety, and sometimes psychotic
manifestations such as hallucinations. The third stage consists of
progressive bradkinesia, dysarthrian axial and extremity dystonia,
paresis, gait disturbances, cogwheel rigidity, intention tremor,
impaired coordination, and a mask-like face. Many of those affected
may be permanently and completely disabled."(1)
Few cases of manganese deficiency or toxicity due to ingestion have
been documented. Only 1%-3% manganese is absorbed via ingestion,
while most of the remaining manganese is excreted in the feces. As
listed in the United States National Agriculture Library, manganese
adequate intake is 1.6-2.3 mg/day for adults. This level of intake is
easily achieved without supplementation by a diverse diet including
fruits and vegetables, which have higher amounts of manganese than
other food types. Patients on a long-term parenteral nutrition should
receive manganese supplementation and should be monitored to
ensure that circulatory levels of manganese are appropriate.
Lowest reportable: <0.1 ng/mL
Normal range: 0.40-0.85 ng/mL
Serum manganese results elevated above the alert value
indicated recent exposure.
Normal specimens have extremely low levels of Mn; therefore,
elevated results could easily be a result of external contamination.
Precautions must be taken to ensure the specimen is not
contaminated. Metal-free serum collection procedures must
be followed and centrifuged serum must be aliquoted into an
acid-washed Mayo metal-free vial. Specimens collected using
an anticoagulant are unacceptable, due to trace amounts of
manganese found in anticoagulants.
High concentrations of gadolinium and iodide are known to interfere
with most metals tests. If either gadolinium or iodide-containing
contrast media has been administered a specimen can not be
collected for 48 hours.
1. Levy BS, Nassetta WJ: Neurologic effects of Manganese in
humans: A review. Int J Occup Environ Health Apr/Jun 2003;
9(2):153-163
2. Chiswell B, Johnson D: Manganese. In Handbook on Metals in
Clinical and Analytical Chemistry. Edited by HG Sigel, H Sigel.
Marcel Dekker, Inc, New York, 1994, pp 479-494
3. Finley J, Davis C: Manganese deficiency and toxicity: Are high
or low dietary amounts of manganese cause for concern?
Biofactors 1999;10:15-24